204 related articles for article (PubMed ID: 36626835)
1. Using Location Intelligence to Evaluate the COVID-19 Vaccination Campaign in the United States: Spatiotemporal Big Data Analysis.
Li Q; Peng JC; Mohan D; Lake B; Euler AR; Weir B; Kan L; Yang C; Labrique A
JMIR Public Health Surveill; 2023 Feb; 9():e39166. PubMed ID: 36626835
[TBL] [Abstract][Full Text] [Related]
2. The Initial Relationship Between the United States Department of Health and Human Services' Digital COVID-19 Public Education Campaign and Vaccine Uptake: Campaign Effectiveness Evaluation.
Williams CJ; Kranzler EC; Luchman JN; Denison B; Fischer S; Wonder T; Ostby R; Vines M; Weinberg J; Petrun Sayers EL; Kurti AN; Trigger S; Hoffman L; Peck JFA
J Med Internet Res; 2023 May; 25():e43873. PubMed ID: 36939670
[TBL] [Abstract][Full Text] [Related]
3. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India.
Godbole S; Diwan V; Das S; Reddy MM; Kalyanasundaram M; Rajendran D; Biswas D; Mamulwar M; Tiwari RR; Majumder J; Mishra A; Muthusamy SK; Memeenao M; Gupta N; Gupta S; George LS; Kadale P; Trushna T; Saha I; Alam U; Kathiresan J; Phukan SK; Sane S; Bhowmik K; Yadav GK; Krishnamurthy V; Gogoi P; Padhye K; Kant R; Ghosh P; Kharat M; Kulkarni A
Front Public Health; 2023; 11():1293600. PubMed ID: 38328539
[TBL] [Abstract][Full Text] [Related]
4. A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
Kim S; Lilani A; Redemptus C; Campana K; Tozan Y
PLoS One; 2024; 19(5):e0300206. PubMed ID: 38709712
[TBL] [Abstract][Full Text] [Related]
5. Information From Same-Race/Ethnicity Experts Online Does Not Increase Vaccine Interest or Intention to Vaccinate.
Gadarian SK; Goodman SW; Michener J; Nyhan B; Pepinsky TB
Milbank Q; 2022 Jun; 100(2):492-503. PubMed ID: 35315950
[TBL] [Abstract][Full Text] [Related]
6. Association Between the United States Department of Health and Human Services' COVID-19 Public Education Campaign and Initial Adult COVID-19 Vaccination Uptake by Race and Ethnicity in the United States, 2020-2022.
Luchman JN; Nighbor T; Kranzler EC; Denison B; Dahlen H; Kim JC; Williams C; Trigger S; Bennett M; Hoffman L; Peck J
Health Promot Pract; 2023 Dec; ():15248399231221159. PubMed ID: 38158812
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the "We Can Do This" Campaign Paid Media and COVID-19 Vaccination Uptake, United States, December 2020-January 2022.
Denison B; Dahlen H; Kim JC; Williams C; Kranzler E; Luchman JN; Trigger S; Bennett M; Nighbor T; Vines M; Petrun Sayers EL; Kurti AN; Weinberg J; Hoffman L; Peck J
J Health Commun; 2023 Sep; 28(9):573-584. PubMed ID: 37528606
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With the Intention to Receive the COVID-19 Vaccine: Cross-sectional National Study.
Kasting ML; Macy JT; Grannis SJ; Wiensch AJ; Lavista Ferres JM; Dixon BE
JMIR Public Health Surveill; 2022 Nov; 8(11):e37203. PubMed ID: 36219842
[TBL] [Abstract][Full Text] [Related]
9. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
10. Randomised experimental evaluation of a social media campaign to promote COVID-19 vaccination in Nigeria.
Evans WD; Bingenheimer JB; Long MW; Ndiaye K; Donati D; Rao NM; Akaba S; Agha S
J Glob Health; 2024 May; 14():05018. PubMed ID: 38779876
[TBL] [Abstract][Full Text] [Related]
11. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
[TBL] [Abstract][Full Text] [Related]
12. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
13. Contribution of community champions to accelerate the uptake of COVID-19 vaccination in Rukwa region, Tanzania, February - October 2022.
Msunyaro E; Rangi J; Haonga T; Kileo N; Mlembwa J; Nyawade S; Machekanyanga Z; Kalinga A; John W; Bukuku MA; Kusena P; Isack I; Mathenge V; Saguti G; Akyoo E; Yoti Z
Pan Afr Med J; 2023; 45(Suppl 1):5. PubMed ID: 37538368
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Hesitancy on Social Media: Building a Public Twitter Data Set of Antivaccine Content, Vaccine Misinformation, and Conspiracies.
Muric G; Wu Y; Ferrara E
JMIR Public Health Surveill; 2021 Nov; 7(11):e30642. PubMed ID: 34653016
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
[TBL] [Abstract][Full Text] [Related]
16. Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
Hernandez I; Dickson S; Tang S; Gabriel N; Berenbrok LA; Guo J
PLoS Med; 2022 Jul; 19(7):e1004069. PubMed ID: 35901171
[TBL] [Abstract][Full Text] [Related]
17. Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.
Rosen B; Waitzberg R; Israeli A; Hartal M; Davidovitch N
Isr J Health Policy Res; 2021 Aug; 10(1):43. PubMed ID: 34340714
[TBL] [Abstract][Full Text] [Related]
18. Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
Bucyibaruta G; Blangiardo M; Konstantinoudis G
Eur J Epidemiol; 2022 Oct; 37(10):1071-1081. PubMed ID: 36121531
[TBL] [Abstract][Full Text] [Related]
19. Identifying health centers in areas with low COVID-19 vaccination rates & high rates of vaccine hesitancy.
Topmiller M; Carrozza M; McCann J; Rankin J
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36706265
[TBL] [Abstract][Full Text] [Related]
20. Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
Bari A; Heymann M; Cohen RJ; Zhao R; Szabo L; Apas Vasandani S; Khubchandani A; DiLorenzo M; Coffee M
Clin Infect Dis; 2022 May; 74(Suppl_3):e4-e9. PubMed ID: 35568473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
